MedStar Georgetown University Hospital to Establish Blood and Marrow Stem Cell Transplantation Program with Hackensack University Medical Center
MedStar Georgetown University Hospital is proud to announce that it has entered into an affiliation with Hackensack University Medical Center (HUMC) to establish a Blood and Marrow Stem Cell Transplantation Program. This agreement opens up greater access to people with cancer, blood diseases and immune deficiency conditions to receive lifesaving treatment in the Washington, D.C., area.
April 10, 2013
A Blood and Marrow Stem Cell Transplant Program for the Nation’s Capital
(Washington, D.C.) – MedStar Georgetown University Hospital is proud to announce that it has entered into an affiliation with Hackensack University Medical Center (HUMC) to establish a Blood and Marrow Stem Cell Transplantation Program. This agreement opens up greater access to people with cancer, blood diseases and immune deficiency conditions to receive lifesaving treatment in the Washington, D.C., area.
HUMC’s program at its John Theurer Cancer Center is among the nation’s largest programs performing nearly 5,000 blood and marrow stem cell transplants since its inception in 1990. This new partnership takes a program that has amassed some of the greatest clinical experience in the development and application of blood and marrow stem cell transplant in the field and combines it with the world-renowned expertise of the Georgetown Lombardi Comprehensive Cancer Center, the only cancer program designated by the National Cancer Institute in the Washington, D.C., region. MedStar Georgetown is home to the world’s largest marrow harvesting site, a program that was started by the US Department of Defense.
“We are proud to partner with a group of physicians whose experience and skills complement ours so superbly,” said Louis M. Weiner, MD, Director of Georgetown Lombardi Comprehensive Cancer Center. “By establishing the only adult academic blood and marrow stem cell transplant program in the Washington, DC area, this agreement will offer patients access to innovative treatment options that are not otherwise available in our region.”
Stem cell transplantation has matured progressively from being an experimental treatment to one that is standard for many types of cancer and serious blood disorders. In recent years, the techniques involved in blood and marrow stem cell transplantation and their success rates have improved significantly.
“We are pleased to be opening a new program at MedStar Georgetown University Hospital in partnership with the John Theurer Cancer Center’s Blood and Marrow Stem Cell Transplantation Program at HackensackUMC and are optimistic this unique collaboration will put us at the forefront of delivering innovative care, and providing tomorrow’s treatment today,” said Andrew L. Pecora, MD, FACP, CPE, President of RCCA. He added, “This is a mutually beneficial relationship that will pair together some of the greatest physicians and facilities in the country. We thank everyone involved for making this forward thinking partnership possible.”
“We are excited by the opportunities that this partnership will generate,” said Richard Goldberg, MD, president, MedStar Georgetown University Hospital. “The John Theurer Cancer Center at HackensackUMC has one of the largest and most respected blood and marrow transplant facilities in the world. The program’s medical team brings incredible expertise and experience and will help us deliver the most advanced care and cutting-edge treatment to improve patients’ outcomes.”
The physicians at the Blood and Marrow Stem Cell Transplantation Program at the John Theurer Cancer Center are members of Regional Cancer Care Associates LLC (RCCA), a physician professional group, which is one of the largest oncology professional groups in the country. These physicians will be providing care and medical oversight for the program at the MedStar Georgetown University Hospital in Washington, D.C.
About MedStar Georgetown University Hospital And Georgetown Lombardi Comprehensive Cancer Center
MedStar Georgetown University Hospital is a not-for-profit, acute-care teaching and research hospital with 609 beds located in Northwest Washington, D.C. Founded in the Jesuit principle of cura personalis—caring for the whole person—MedStar Georgetown is committed to offering a variety of innovative diagnostic and treatment options within a trusting and compassionate environment.
MedStar Georgetown’s centers of excellence include neurosciences, transplant, cancer and gastroenterology. Along with Magnet® nurses, internationally recognized physicians, advanced research and cutting-edge technologies, MedStar Georgetown’s healthcare professionals have a reputation for medical excellence and leadership. MedStar Georgetown University Hospital—Knowledge and Compassion Focused on You.
Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center and MedStar Georgetown University Hospital, seeks to improve the diagnosis, treatment and prevention of cancer through innovative basic and clinical research, patient care, community education and outreach, and the training of cancer specialists of the future. Georgetown Lombardi is one of only 41 comprehensive cancer centers in the nation, as designated by the National Cancer Institute, (NCI), and the only one in the Washington, DC, area.
About Hackensack University Medical Center
HackensackUMC, a non-profit teaching and research hospital located in Bergen County, New Jersey, is the largest provider of inpatient and outpatient services in the state, and home to the only Level II Trauma Center in the county. This 775-bed facility has gone beyond traditional thinking by creating an entire campus of care, including: the Heart & Vascular Hospital, the John Theurer Cancer Center, the Joseph M. Sanzari Children’s Hospital, and the Donna A. Sanzari Women’s Hospital. As a result of using science and creativity to push medicine further, HackensackUMC was listed as the number one hospital in New Jersey and one of the top four New York metro area hospitals by the U.S. News & World Report, and has received nine national rankings in: Cancer; Cardiology & Heart Surgery; Ear, Nose & Throat; Gastroenterology; Geriatrics; Neurology & Neurosurgery; Orthopedics; Urology; and the Joseph M. Sanzari Children’s Hospital ranked as one of the Top 25 Best Children’s Hospitals for Neurology and Neurosurgery in the 2012-13 Best Children’s Hospitals list. The medical center has also been named one of the Truven Health Analytics 100 Top Hospitals® and one of America's 50 Best Hospitals by HealthGrades®. It is listed among the Leapfrog Top Hospitals List, received 18 Gold Seals of Approval™ by the Joint Commission, and is listed as one of the 50 Best Hospitals in America by Becker’s Hospital Review. It was the first hospital in New Jersey and second in the nation to become a Magnet® recognized hospital for nursing excellence. The medical center is the Hometown Hospital of the New York Giants and the New York Red Bulls, and remains committed to its community through fundraising and community events.
About Regional Cancer Care Associates
Regional Cancer Care Associates LLC is the largest oncology physician network in New Jersey. RCCA was created to maintain access to high quality cancer care and clinical trials while controlling cost. Physicians in our integrated, value-based cancer care network accept their responsibility to work with insurance companies, hospitals and referring physicians to provide patients continued access to the highest quality, cutting edge therapies while reducing the cost of cancer care.
Regional Cancer Care Associates LLC extends across New Jersey with more than 80 cancer care specialists and is supported by 500 employees at more than 20 care delivery sites, providing care to more than 20,000 new patients annually and over 80,000 existing patients.
Patient Contact: 202-342-2400
Back to Top